Home » Topics » BioWorld

BioWorld
RSS

PATCH SALES IGNITE ALZA REVENUES

July 23, 1992

ROCHE GETS HIV TESTING PERMITS IN NEW YORK

July 23, 1992

DYNAGEN AMENDS OFFERING

July 23, 1992

AMGEN STOCK HITS FOUR-MONTH HIGH

July 23, 1992

ALTEON'S DECLINE POINTS TO CAUTIOUS STREET

July 23, 1992

AIDS CONFERENCE: UPJOHN CLAIMS POTENT AIDS DRUG

July 23, 1992

FDA APPROVES MERIDIAN DIAGNOSTIC

July 22, 1992

DYNAGEN SIGNS DEAL WITH MUREX

July 22, 1992

BTGC's GROWTH HORMONE APPROVED IN ISRAEL

July 22, 1992

ENZON LICENSES DRUG TO TREAT FABRY'S

July 22, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...